Original Article

The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection

Abstract

Background: We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19).

Methods: Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13th of Mar 2020 and 12th of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients’ demographic and clinical characteristics and the factors associated with morbidity and mortality were analyzed.

Results: Of all the patients, 773 (95.8%) were alive and 34 (4.24%) died. The fatality rate was 4.2%. There were differences between the age groups in terms of fatality rate (P<0.001). The fatality rate in patients above the age of 65 yr was significantly higher. The fatality rate in the male gender was 2.44 times higher (P<0.05). It was 1.104 times higher in advanced age (P<0.001) and 10.893 times higher in patients with at least one comorbid disease (P<0.05). Hypertension increased mortality by 3.635 times (P<0.05) and chronic pulmonary diseases by 2.926 times (P<0.05).

Conclusion: Advanced age, male gender and accompanying chronic diseases have adverse effects on the course and severity of the disease and hospitalization. They also increased the rate and risk of mortality.

1. Li Q, Guan X, Wu P, et al (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 382 (13): 1199–1207.
2. Chan JF-W, Yuan S, Kok K-H, et al (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.The Lancet, 395 (10223): P514–523.
3. Guan W, Ni Z, Hu Y, et al (2020). Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med, 382: 1708-1720.
4. Lauer SA, Grantz KH, Bi Q, et al (2020). The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med, 172 (9): 577–582.
5. Wu D, Wu T, Liu Q, Yang Z (2020). The SARS-CoV-2 outbreak: What we know. Int J Infect Dis, 94: 44–48.
6. The Novel Coronavirus Pneumonia Emer-gency Response Epidemiology Team (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. Chi-na CDC Weekly, 2 (8): 113–122.
7. Song F, Shi N, Shan F, et al (2020). Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology, 295 (1): 210–217.
8. Qin C, Zhou L, Hu Z, et al (2020). Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 71 (15): 762–768.
9. Göker H, Aladağ-Karakulak E, Demiroğlu H, et al (2020). The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci, 50 (4): 679–683.
10. Wang D, Hu B, Hu C, et al (2020). Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323 (11): 1061–1069.
11. Zhao X, Zhang B, Li P, et al (2020). Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv, doi:10.1101/2020.03.17.20037572.
12. Zhao S, Lin Q, Ran J, et al (2020). Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis, 92: 214–217.
13. Calder PC, Bosco N, Bourdet-Sicard R, et al (2017). Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev, 40: 95–119.
14. Jaillon S, Berthenet K, Garlanda C (2019). Sexual Dimorphism in Innate Immunity. Clin Rev Allergy Immunol, 56 (3): 308–321.
15. Cai H (2020). Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med, 8 (4): e20.
16. Zhou F, Yu T, Du R, et al (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395 (10229): 1054–1062.
17. Yu D, Lin Q, Chiu AP, He D (2017). Effects of reactive social distancing on the 1918 influenza pandemic. PLoS One, 12 (7): e0180545.
18. Earn DJD (2012). Effects of School Closure on Incidence of Pandemic Influenza in Alberta, Canada. Ann Intern Med, 156 (3): 173-81.
19. Prem K, Liu Y, Russell TW, et al (2020). The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health, 5 (5): e261–e270.
Files
IssueVol 50 No 4 (2021) QRcode
SectionOriginal Article(s)
Published2021-04-05
DOI https://doi.org/10.18502/ijph.v50i4.5996
Keywords
COVID-19 Chronic disease Morbidity Mortality

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Aslaner H, Aslaner HA, Gökçek MB, Benli AR, Yıldız O. The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection. Iran J Public Health. 50(4):721-727.